Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3342
Peer-review started: October 4, 2020
First decision: December 30, 2020
Revised: January 22, 2021
Accepted: March 3, 2021
Article in press: March 3, 2021
Published online: May 16, 2021
Processing time: 207 Days and 3.5 Hours
Bone cement implantation syndrome (BCIS) is characterized by hypotension, arrhythmia, diffuse pulmonary microvascular embolism, shock, cardiac arrest, any combination of these factors, or even death following bone cement implanta
An 80-year-old patient with pemphigus and Parkinson’s disease underwent total hip replacement under spinal subarachnoid block and developed acute pulmonary embolism after bone cement implantation. The patient received mask mechanical ventilation with a continuous intravenous infusion of adrenaline (2 μg/mL) at a rate of 30 mL/h. Subsequently, the symptoms of BCIS were markedly alleviated, and the infusion rate of adrenaline was gradually reduced until the infusion was completely stopped 45 min later. The patient was then transferred to the Department of Orthopedics, and anticoagulation therapy began at 12 h postoperatively. No other complications were observed.
This is a rare case of BCIS in a high-risk patient with pemphigus and Parkinson’s disease.
Core Tip: Bone cement implantation syndrome (BCIS) is an important cause of death and disability during the perioperative period of total hip replacement. The present patient with pemphigus and Parkinson's disease had a higher risk of BCIS than the general population due to pathophysiological changes and current medications. Therefore, the choice of anesthetic method for such patients must take full account of their current conditions. In addition, vital signs must be closely monitored intraopera
